rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Joanne Waldstreicher

Director

Company insider

Files Form 4 as: Director, Structure Therapeutics; Director, Becton, Dickinson and.

In numbers

Trades disclosed
9
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
2
Companies where not an officer
2
First trade
24 Jul 2023
Last trade
17 Jun 2026
Last filed
18 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
GPCR Structure TherapeuticsDirector · Biotechnology · last 17 Jun 20260 buys · 0 sells
BDX Becton, Dickinson andDirector · Medical Devices · last 27 Jan 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
17 Jun 2026filed 18 Jun 2026GPCR Structure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—39,453 at $0.00filing
17 Jun 2026filed 18 Jun 2026GPCR Structure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—39,453 at $0.00filing
27 Jan 2026filed 29 Jan 2026BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code A—1,098 at $0.00filing
27 Jan 2026filed 29 Jan 2026BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code A—1,098 at $0.00filing
23 Jun 2025filed 25 Jun 2025GPCR Structure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—51,804 at $0.00filing
28 Jan 2025filed 30 Jan 2025BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code A—930 at $0.00filing
25 Jun 2024filed 27 Jun 2024GPCR Structure Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—37,500 at $0.00filing
23 Jan 2024filed 25 Jan 2024BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code A—900 at $0.00filing
24 Jul 2023filed 24 Jul 2023BDX Becton, Dickinson andMedical DevicesSEC FORM 4 Code A—419 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Michael FeldEVP, Chief Revenue Officer · EVP, Chief Revenue Officer at Becton Dickinson & Co, filing Form 4 there in the last year
Crespo Blas CollChief Medical Officer · Chief Medical Officer at Structure Therapeutics, filing Form 4 there in the last year
Vitor RoqueEVP & Chief Financial Officer · EVP & Chief Financial Officer at Becton Dickinson & Co, filing Form 4 there in the last year
Xichen LinChief Scientific Officer · Chief Scientific Officer at Structure Therapeutics, filing Form 4 there in the last year
Thomas E. Polen Jr.Chairman, CEO and President · Chairman, CEO and President at Becton Dickinson & Co, filing Form 4 there in the last year